Skip to main content
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. — Investor Relations & Filings

Ticker · JSPR ISIN · US4718712023 US Professional, scientific and technical activities
Filings indexed 422 across all filing types
Latest filing 2019-10-09 Regulatory Filings
Country US United States of America
Listing US JSPR

About Jasper Therapeutics, Inc.

https://jaspertx.com/

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies targeting mast and hematopoietic stem cells. The company's lead product candidate is briquilimab, a monoclonal antibody that targets c-Kit (CD117). This therapeutic is designed to deplete mast cells for the treatment of chronic immunological and inflammatory diseases. Jasper Therapeutics is conducting clinical studies to evaluate briquilimab in patients with chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to provide safer and more effective therapies for patients with chronic mast cell-driven diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings
2019-10-09 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 for an initial public offering by Amplitude Healthcare Acquisition Corporation. The text includes detailed information about the securities being registered, offering price, underwriting, and other offering details. This type of filing is related to capital raising and financing activities, specifically the registration of securities for an IPO. Therefore, it fits the category of Capital/Financing Update (CAP). The document is not an annual report, earnings release, or any other report type but a registration statement for securities offering.
2019-09-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.